Journal of Leukocyte Biology BioLegend: Treg, Th17, Stem Cell
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on January 1, 2006

Published online before print November 7, 2005
This Article
Right arrow Full Text (Reprint (PDF))
Right arrow All Versions of this Article:
jlb.0605308v1
79/1/147    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Han, H.
Right arrow Articles by Nathan, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Han, H.
Right arrow Articles by Nathan, C.
© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0605308


Received for publication June 8, 2005.
Revised August 2, 2005.
Accepted for publication September 10, 2005.


Article

Chemical inhibitors of TNF signal transduction in human neutrophils point to distinct steps in cell activation

Hyunsil Han *, Julia Roberts *, Olivia Lou {dagger}{ddagger}, Willam A. Muller {dagger}{ddagger}, Noah Nathan , and Carl Nathan *{ddagger}{sect}@

Departments of *Microbiology and Immunology and {dagger}Pathology and Laboratory Medicine, Weill Medical College of Cornell University, and Graduate Programs in {ddagger}Immunology and Microbial Pathogenesis and {sect}Molecular Biology, Weill Graduate School of Medical Sciences of Cornell University, New York, New York

@ To whom correspondence should be addressed. E-mail: cnathan{at}med.cornell.edu.


   Abstract

Chemical screening identified three small compounds that selectively inhibited activation of the respiratory burst (RB) of human neutrophils in response to tumor necrosis factor (TNF) and formylated peptide but not phorbol ester and spared the ability of neutrophils to kill bacteria. These compounds partially inhibited TNF-triggered cytoskeletal rearrangements without blocking adhesion or transmigation of polymorphonuclear neutrophils through TNF-activated monolayers of endothelial cells. The compounds were nontoxic to neutrophils and endothelial cells. They had no direct inhibitory effect on the tyrosine kinases Src, Syk, or Pyk2. However, their differential effects on cell spreading, bacteria-induced RB, TNF-induced degranulation, TNF-induced protein tyrosine phosphorylation, and TNF-induced Syk activation suggested that each may act on different elements of neutrophil signaling pathways.

Key Words: phox • respiratory burst • tumor necrosis factor




This article has been cited by other articles:


Home page
J. Immunol.Home page
F. J. Roca, I. Mulero, A. Lopez-Munoz, M. P. Sepulcre, S. A. Renshaw, J. Meseguer, and V. Mulero
Evolution of the Inflammatory Response in Vertebrates: Fish TNF-{alpha} Is a Powerful Activator of Endothelial Cells but Hardly Activates Phagocytes
J. Immunol., October 1, 2008; 181(7): 5071 - 5081.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2005 by the Society for Leukocyte Biology.